HTN risk up for african-american live kidney donors

HTN risk up for african-american live kidney donors
African-American live kidney donors have a significantly increased risk of hypertension compared with non-donors, according to a study published online Oct. 24 in the American Journal of Transplantation.

(HealthDay)—African-American live kidney donors have a significantly increased risk of hypertension compared with non-donors, according to a study published online Oct. 24 in the American Journal of Transplantation.

To examine the risk of hypertension and kidney disease in donors, Mona D. Doshi, M.D., of Wayne State University in Detroit, and associates evaluated 103 African-American live kidney donors, who donated between 1993 and 2006 at two transplant centers, and 235 matched non-donors from the Coronary Artery Risk Development in Young Adults prospective cohort study. Donors and non-donors were followed for a mean of 6.8 or 6.4 years, respectively.

The researchers found that donors had a significantly increased hypertension risk compared with non-donors (40.8 versus 17.9 percent; relative risk, 2.4). Just over half (52.4 percent) of the donors with hypertension were untreated. Of the donors, 15.5 percent had an estimated <60 mL/min/1.73 m², 5.8 percent had microalbuminuria, and none of them were on dialysis.

"The data from our retrospective study demonstrates that live is associated with increased risk of hypertension in African-Americans," the authors write. "At this time, results of the current study should not dissuade African-Americans from being a live , but does raise awareness about the importance of donor follow-up."

One of the authors disclosed financial ties to the pharmaceutical industry.

More information: Abstract
Full Text (subscription or payment may be required)

add to favorites email to friend print save as pdf

Related Stories

Never too old to donate a kidney?

Oct 28, 2011

People over age 70 years of age can safely donate a kidney, according to a study appearing in an upcoming issue of the Clinical Journal of the American Society Nephrology (CJASN). The results provide good news for patients ...

Recommended for you

Using feminist theory to understand male rape

8 hours ago

Decades of feminist research have framed rape and sexual assault as a 'women's issue', leaving little room for the experiences of male victims. But a new study published in the Journal of Gender Studies suggests that feminist ...

Simulation-based training improves endoscopy execution

Oct 18, 2014

(HealthDay)—Simulation-based training (SBT) improves clinicians' performance of gastrointestinal endoscopy in both test settings and clinical practice, according to research published in the October issue ...

Data sharing in pharmaceutical industry shows progress

Oct 16, 2014

To enhance the transparency of clinical trials for new drugs, a number of pharmaceutical firms have begun sharing data with investigators outside their own companies. Brian L. Strom, chancellor of Rutgers Biomedical and Health ...

Swiss drug maker Roche posts flat 3Q sales

Oct 16, 2014

(AP)—Swiss drugmaker Roche Holding AG has reported "stable" or flat sales for the first nine months of 2013 but says the results show strong demand for its cancer drugs and emerging new products.

User comments